| NCT00393380 | The Emmes Company, LLC|National Heart, Lung, and Blood Institute (NHLBI) | Leukemia, Myeloid, Chronic|Anemia, Aplastic|Myelofibrosis|Lymphoma|Hodgkin Disease|Leukemia, Lymphocytic, Chronic|Leukemia, Myelocytic, Acute|Leukemia, Lymphocytic, Acute | 2006-09 | PHASE2 |
| NCT00577863 | Eli Lilly and Company | Osteoporosis | 2008-01 | PHASE3 |
| NCT00557310 | Eli Lilly and Company | Osteoporosis, Postmenopausal | 2007-11 | PHASE4 |
| NCT00542425 | Radius Health, Inc. | Osteoporosis | 2007-04 | PHASE2 |
| NCT00927186 | Eli Lilly and Company | Osteoporosis, Post-menopausal | 2009-07 | PHASE4 |
| NCT03720886 | Shenzhen Salubris Pharmaceuticals Co., Ltd. | Postmenopausal Osteoporosis | 2018-10-01 | PHASE1|PHASE2 |
| NCT02972424 | Hospital for Special Surgery, New York|Weill Medical College of Cornell University | Osteoporotic Fractures | 2017-05-01 | PHASE2 |
| NCT03735537 | University of Edinburgh|NHS Lothian | Osteogenesis Imperfecta | 2016-11-01 | PHASE4 |
| NCT04669782 | University of Milano Bicocca | Bone Metabolism Disorder|Aging Disorder|Osteoporosis | 2020-11-24 | NA |
| NCT01750086 | Massachusetts General Hospital | Postmenopausal Osteoporosis | 2013-01 | PHASE4 |
| NCT01321723 | Unigene Laboratories Inc.|GlaxoSmithKline | Postmenopausal Osteoporosis | 2011-02 | PHASE2 |
| NCT04522622 | Ditte Hansen|Odense University Hospital|Steno Diabetes Center Copenhagen|Rigshospitalet, Denmark|Aalborg University Hospital | Adynamic Bone Disease|Chronic Kidney Diseases|Cardiac Disease|Chronic Kidney Disease-Mineral and Bone Disorder | 2021-12-15 | PHASE4 |
| NCT00191802 | Eli Lilly and Company | Osteoporosis | 2003-09 | PHASE3 |
| NCT01309399 | Health Research, Inc.|Hospital for Special Surgery, New York|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Osteoporosis | 2010-08 | NA |
| NCT01153425 | University of Pennsylvania|Eli Lilly and Company|Novartis Pharmaceuticals|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Osteoporosis, Osteopenia | 2008-07 | PHASE4 |
| NCT00543023 | Eli Lilly and Company | Osteoporosis, Post-Menopausal | 2003-06 | PHASE3 |
| NCT05866029 | Peking Union Medical College Hospital | Osteoporotic Fractures | 2023-05-26 | NA |
| NCT00065637 | University of California, San Francisco|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Osteopenia|Osteoporosis | 2003-12 | PHASE3 |
| NCT01473589 | Eli Lilly and Company | Femur Neck Fracture | 2012-02 | PHASE3 |
| NCT06164795 | 424 General Military Hospital | Osteoporosis, Postmenopausal | 2023-11-25 | |
| NCT04026256 | Massachusetts General Hospital|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Postmenopausal Osteoporosis | 2019-09-02 | PHASE4 |
| NCT04921124 | Norfolk and Norwich University Hospitals NHS Foundation Trust|University of East Anglia|Ministry of Defence, United Kingdom | Stress Fracture | 2021-05-24 | PHASE3 |
| NCT01011556 | Eli Lilly and Company|TransPharma Medical | Osteoporosis | 2009-11 | PHASE2 |
| NCT03133195 | King Chulalongkorn Memorial Hospital | Unstable Intertrochanteric Fracture|Pertrochanteric Fracture of Femur, Closed | 2017-05-17 | PHASE3 |
| NCT00670501 | Eli Lilly and Company | Osteoporosis, Postmenopausal | 1996-08 | PHASE3 |
| NCT05151484 | Madhumathi Rao|National Institute on Aging (NIA) | Age-Related Osteoporosis | 2022-03-21 | PHASE4 |
| NCT00696644 | Eli Lilly and Company | Osteoporosis, Postmenopausal|Osteoporosis | 2008-06 | |
| NCT00594906 | University of Rochester|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|National Institutes of Health (NIH) | Pelvic Fracture | 2008-01 | NA |
| NCT07242612 | Khyber Medical University Peshawar | Osteoporosis|Osteoporosis, Postmenopausal | 2025-10-01 | NA |
| NCT01293292 | Sheffield Teaching Hospitals NHS Foundation Trust | Osteoporosis | 2011-01 | PHASE4 |
| NCT02416271 | Eli Lilly and Company | Osteoporosis | 2001-04 | PHASE4 |
| NCT01473602 | Eli Lilly and Company | Femur Neck Fracture | 2012-01 | PHASE3 |
| NCT01753856 | Eli Lilly and Company | Osteoporosis | 2013-01 | PHASE4 |
| NCT00446589 | Papageorgiou General Hospital | Osteoporosis | 2006-07 | PHASE4 |
| NCT06898060 | Qilu Pharmaceutical Co., Ltd. | Postmenopausal Women With Osteoporosis | 2025-06 | PHASE3 |
| NCT00191425 | Eli Lilly and Company | Osteoporosis, Postmenopausal | 2002-08 | PHASE4 |
| NCT02563353 | Odense University Hospital|University of Southern Denmark|Copenhagen University Hospital, Denmark|Esbjerg Hospital - University Hospital of Southern Denmark|Sygehus Lillebaelt|Odense Patient Data Explorative Network|Region of Southern Denmark | Osteoporosis | 2015-11 | NA |
| NCT02202603 | Entera Bio Ltd. | Drug Safety | 2011-07 | PHASE1 |
| NCT01279187 | University of Michigan|Eli Lilly and Company | Implant | 2011-02 | PHASE2 |
| NCT01155232 | University Health Network, Toronto | Osteoporosis | 2004-11 | |
| NCT02090244 | University Hospital, Linkoeping|Medical Research Council of Southeast Sweden | Spinal Stenosis | 2012-08 | PHASE4 |
| NCT01760798 | Post Graduate Institute of Medical Education and Research, Chandigarh | Osteoporosis | 2012-01 | NA |
| NCT04473989 | Peking University Third Hospital | Colles´ Fracture | 2021-06-01 | PHASE2 |
| NCT01945788 | Bio Sidus SA | Postmenopausal Osteoporosis With Pathological Fracture | 2013-06 | PHASE4 |
| NCT02824718 | Assistance Publique - H?pitaux de Paris|Ministry of Health, France | Autosomal Dominant Hypocalcemia OR Primary Hypoparathyroidism Related to Other Cause But Complicated by Hypercalciuria Under Treatment | 2017-06-06 | PHASE2 |
| NCT00259298 | Eli Lilly and Company | Osteoporosis | 2005-11 | PHASE4 |
| NCT02656810 | Pfenex, Inc | Osteoporosis | 2015-12 | PHASE1 |
| NCT03692143 | Nanfang Hospital, Southern Medical University | Osteoporosis, Postmenopausal|Vertebral Fracture|Quality of Life | 2017-01-01 | |
| NCT03770338 | The University of Hong Kong | Osteoporosis|Fusion of Spine, Lumbar Region | 2019-03-01 | NA |
| NCT01734824 | Medical University of Vienna | Bone Marrow Oedema Syndrome|High Turnover Bone Disease|Quality of Life | 2012-05 | PHASE4 |
| NCT00489918 | Zosano Pharma Corporation | Osteoporosis | 2007-06 | PHASE2 |
| NCT02156960 | Shinshu University | Osteoporosis | 2014-05 | PHASE4 |
| NCT00343252 | Eli Lilly and Company | Osteoporosis, Postmenopausal|Back Pain|Spinal Fracture | 2006-06 | PHASE3 |
| NCT00826228 | Thomas J. Schnitzer|Eli Lilly and Company|Shirley Ryan AbilityLab | Osteoporosis|Bone Loss|Spinal Cord Injury | 2009-06 | PHASE4 |
| NCT00191893 | Eli Lilly and Company | Osteoporosis | 2003-09 | PHASE3 |
| NCT04589819 | University of South Carolina|United States Department of Defense|Eisenhower Army Medical Center|Moncrief Army Health Clinic | Stress Fracture of Tibia or Fibula | 2022-12-08 | PHASE4 |
| NCT00754442 | University of Maryland, Baltimore | Secondary Hyperparathyroidism | 2007-02 | NA |
| NCT00543218 | Eli Lilly and Company | Osteoporosis, Post-Menopausal | 2002-12 | PHASE3 |
| NCT00046137 | Eli Lilly and Company | Osteoporosis, Postmenopausal | | PHASE3 |
| NCT00433160 | Eli Lilly and Company | Osteoporosis | 2007-01 | PHASE3 |
| NCT05018637 | Inbo Han | Vertebral Compression Fracture|Osteoporotic Fractures | 2020-09-01 | PHASE2 |
| NCT06061354 | Universidad de Valparaiso|Universidade Federal Fluminense | Bone Regeneration | 2023-08-23 | PHASE4 |
| NCT00191867 | Eli Lilly and Company | Osteoporosis | 2005-02 | PHASE2 |
| NCT00035256 | Eli Lilly and Company | Osteoporosis, Postmenopausal | 2001-10 | PHASE4 |
| NCT06558188 | Massachusetts General Hospital|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Osteoporosis, Postmenopausal|Osteoporosis | 2025-02-03 | PHASE4 |
| NCT02304887 | Toshihiko Kono | Osteoporosis | 2006-01 | |
| NCT00239629 | Eli Lilly and Company | Postmenopausal Osteoporosis | 2005-09 | PHASE4 |
| NCT01173081 | Ohio Orthopedic Center of Excellence|Eli Lilly and Company | Fractures | 2010-07 | PHASE4 |
| NCT06951776 | Peking University Third Hospital | Circadian Rhythm Disorders|Osteoporosis | 2025-05-01 | NA |
| NCT02023411 | Post Graduate Institute of Medical Education and Research, Chandigarh | Diabetic Neuropathic Arthropathy | 2014-01 | PHASE2 |
| NCT00439244 | Novartis | Osteoporosis | 2006-12 | PHASE3 |
| NCT06264609 | Paul F Netzel | Osteoporosis | 2024-02-01 | PHASE4 |
| NCT00532545 | Eli Lilly and Company | Osteoporosis, Post-Menopausal | 2003-04 | PHASE4 |
| NCT02091492 | Medical University of Vienna | Osteoporosis, Age-Related|Humeral Fractures | 2014-06 | PHASE3 |
| NCT00761332 | Eli Lilly and Company | Osteoporosis | 2008-02 | |
| NCT01343004 | Radius Health, Inc. | Osteoporosis|Postmenopausal Osteoporosis | 2011-04 | PHASE3 |
| NCT01292252 | Shane Burch|Eli Lilly and Company | Lumbar Spondylosis|Lumbar Spondylolisthesis|Adult Degenerative Lumbar Scoliosis | 2011-08 | PHASE4 |
| NCT01166958 | University of Wisconsin, Madison | Osteoporosis | 2010-09 | PHASE4 |
| NCT01679080 | University of Aarhus | Osteogenesis Imperfecta | 2012-11 | PHASE2 |
| NCT00697463 | Columbia University|Eli Lilly and Company | Menopause|Fracture|Osteoporosis | 2008-08-20 | PHASE2|PHASE3 |
| NCT01705587 | Susan L. Greenspan|University of Pittsburgh|Eli Lilly and Company | Osteoporosis|Atypical Femoral Fracture | 2012-12 | PHASE4 |
| NCT03072147 | Christopher Ritchlin|Eli Lilly and Company|University of Rochester|Duke University|Milton S. Hershey Medical Center | Knee Osteoarthritis|Cartilage Degeneration | 2017-05-01 | PHASE2 |
| NCT00759772 | Massachusetts General Hospital|Eli Lilly and Company | Anorexia Nervosa|Osteoporosis | 2008-09 | PHASE2 |
| NCT00623974 | M.D. Anderson Cancer Center|Eli Lilly and Company | Hypocalcemia | 2008-05 | PHASE2 |
| NCT00051558 | Eli Lilly and Company | Osteoporosis | 2002-11 | PHASE3 |
| NCT02025179 | Northwestern University|United States Department of Defense | Spinal Cord Injury|Bone Loss|Osteoporosis | 2013-01 | PHASE2 |
| NCT06303284 | University of Calgary | Ankle Fractures | 2025-01-01 | PHASE1|PHASE2 |
| NCT01604057 | Azelon Pharmaceuticals | Osteoporosis|Osteopenia | 2011-11 | PHASE2 |
| NCT02440581 | Hartmut Malluche, MD|Wright State University|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Kidney Failure, Chronic | 2015-07-01 | NA |
| NCT03994172 | VA Office of Research and Development|University of California, San Francisco | Male Osteoporosis | 2019-07-01 | PHASE4 |
| NCT00624481 | Nastech Pharmaceutical Company, Inc. | Osteopenia|Osteoporosis | 2008-03 | PHASE2 |
| NCT00079924 | Eli Lilly and Company | Postmenopausal Osteoporosis | 2004-11 | PHASE4 |
| NCT04974723 | Radius Health, Inc.|PRA Health Sciences | Osteoporosis, Postmenopausal | 2021-07-01 | |
| NCT02571140 | Entera Bio Ltd. | Drug Safety and Bioavailability | 2013-10 | PHASE1 |
| NCT01105832 | University Hospital, Linkoeping | Humeral Fracture | 2010-04 | PHASE4 |
| NCT01611571 | Columbia University|Alliance for Better Bone Health | Osteoporosis | 2003-12 | PHASE3 |
| NCT00896532 | Amgen | Low Bone Mineral Density|Postmenopausal Osteoporosis | 2009-06-03 | PHASE2 |
| NCT00190944 | Eli Lilly and Company | Colles´ Fracture | 2004-12 | PHASE2 |
| NCT01430104 | Eli Lilly and Company | Osteoporosis | 2011-08 | PHASE4 |
| NCT01400516 | Brigham and Women´s Hospital|Eli Lilly and Company | Rheumatoid Arthritis | 2011-08 | PHASE4 |
| NCT01796301 | Amgen | Postmenopausal Osteoporosis | 2013-01-31 | PHASE3 |
| NCT00005006 | Helen Hayes Hospital|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Osteoporosis | 1987-09 | PHASE2 |
| NCT02176382 | Massachusetts General Hospital | Postmenopausal Osteoporosis | 2014-08 | PHASE4 |
| NCT01535027 | Medical University of Vienna | Osteoporosis | 2006-03 | PHASE4 |
| NCT03472846 | Medical University of Vienna|St. Vincent Hospital, Vienna | Postmenopausal Osteoporosis|Diabetes Type 2 | 2017-03-01 | PHASE4 |
| NCT00347737 | Leland Graves III, MD|University of Kansas | Osteoporosis | 2006-06 | NA |
| NCT00668941 | Helen Hayes Hospital|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|Health Research, Inc. | Osteoporosis | 2005-09 | PHASE2 |
| NCT04196855 | University of East Anglia|Ministry of Defence, United Kingdom|Darlington Memorial Hospital|Clinical Research and Trials Unit (Norfolk & Norwich University Hospital, UK) | Stress Fracture|Parathyroid Hormone | 2019-12-23 | PHASE3 |
| NCT04750460 | Saint Petersburg State University, Russia | Secondary Hyperparathyroidism|Chronic Kidney Disease-Mineral and Bone Disorder|Dialysis|Hypocalcemia|Hypoparathyroidism | 2021-03-01 | PHASE3 |
| NCT01225055 | Thomas J. Schnitzer|Edward Hines Jr. VA Hospital|University of Illinois at Chicago|Congressionally Directed Medical Research Programs | Spinal Cord Injury|Bone Loss|Osteoporosis | 2010-10 | PHASE2 |
| NCT00926380 | Massachusetts General Hospital|Amgen | Osteoporosis | 2009-06 | PHASE2 |
| NCT04206618 | 424 General Military Hospital|Beth Israel Deaconess Medical Center | Osteoporosis, Postmenopausal | 2019-06-01 | |
| NCT01896011 | University Health Network, Toronto|The Physicians´ Services Incorporated Foundation|Eli Lilly and Company | Non Displaced Atypical Femoral Fractures | 2013-07 | PHASE3 |
| NCT00542984 | Eli Lilly and Company | Osteoporosis, Postmenopausal | 2003-08 | PHASE3 |
| NCT00503399 | Eli Lilly and Company | Osteoporosis | 2007-07 | PHASE3 |
| NCT00191321 | Eli Lilly and Company | Osteoporosis | 2004-07 | PHASE3 |
| NCT01063504 | University Hospital, Linkoeping | Osteoarthritis of the Knee | 2010-02 | PHASE2 |
| NCT00471237 | GlaxoSmithKline | Osteoporosis | 2007-05-14 | PHASE2 |
| NCT02472782 | 251 Hellenic Air Force & VA General Hospital|Hellenic Osteoporosis Foundation (www.http:++heliost.gr+en+) | Osteoporosis, Postmenopausal|Osteoporosis, Steroid Induced | 2015-05 | |
| NCT04879420 | Brigham and Women´s Hospital | Osteoporosis | 2020-10-29 | |
| NCT01440803 | Elizabeth Shane|Food and Drug Administration (FDA) | Adult Idiopathic Generalized Osteoporosis | 2012-08-02 | PHASE2 |
| NCT01171690 | Mayo Clinic | Hypoparathyroidism Post-surgical | 2010-11 | PHASE2 |
| NCT00535860 | TransPharma Medical|Eli Lilly and Company | Osteoporosis | 2008-04 | PHASE2 |
| NCT00887354 | Eli Lilly and Company | Osteoporosis | 2009-04 | PHASE4 |
| NCT02223416 | Gedeon Richter Plc. | Healthy | | PHASE1 |
| NCT01360424 | Helsinki University Central Hospital|Eli Lilly and Company | Osteoporosis | 2011-05 | PHASE4 |
| NCT01656629 | Johns Hopkins University | Low Bone Density | 2012-08 | NA |
| NCT00131469 | Oregon Health and Science University|Eli Lilly and Company|Osteogenesis Imperfecta Foundation|National Institutes of Health (NIH)|National Center for Research Resources (NCRR) | Osteogenesis Imperfecta | 2005-06 | PHASE4 |
| NCT00414973 | Eli Lilly and Company | Osteoporosis | 2006-12 | PHASE3 |